Doctor profile · Federal record

Dr. Fadi Kayali, M.D.

Medical Oncology Physician (CMS: Hematology/Oncology) · Internal Medicine Physician · Hematology (Internal Medicine) Physician · Hospice and Palliative Medicine (Internal Medicine) Physician · Sarasota, FL

  • NPI 1003031212
  • Accepts Medicare
  • MIPS 75.0 / 100 · 2023
  • 29 yrs in practice
  • Licensed in 2 states
  • Male
  • Group practice
  • No sanctions

Practice & contact

NPPES Updated May 11, 2026
Primary practice
600 N Cattlemen RD, Suite 200
Sarasota, FL 342326422
(941) 377-9993
fax (941) 343-0026
Mailing address
Po Box 102222, Attn: Credentialing
Atlanta, GA 303682222

Credentials & registration

NPPES · NUCC
NPI registered
April 2007 — 19 yrs on file
Profile last updated
August 9, 2022
Year of graduation
1997 — 29 yrs since
Specialty taxonomy
207RX0202X — NUCC code
State licenses (2)
Florida #ME106289 · Michigan #4301083320
Medicaid
FL #001954000

Federal sanctions & exclusions

OIG LEIE Updated May 11, 2026

No sanctions, exclusions or revocations on file

Checked against OIG LEIE on NPI 1003031212. Last verified May 11, 2026.

Medicare procedures · 2023

Top services delivered

CMS Provider Utilization
Total services
259,482
Distinct HCPCS
10
Medicare allowed
$3,608,485
HCPCS Description Services Patients Avg allowed
Q0138 Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) 99,450 105 $0
J9299 Injection, nivolumab, 1 mg 29,980 14 $30
J9271 Injection, pembrolizumab, 1 mg 18,400 16 $54
J9263 Injection, oxaliplatin, 0.5 mg 17,100 12 $0
J0897 Injection, denosumab, 1 mg 13,080 94 $23
J0185 Injection, aprepitant, 1 mg 12,350 28 $2
J0885 Injection, epoetin alfa, (for non-esrd use), 1000 units 12,270 51 $8
J1756 Injection, iron sucrose, 1 mg 10,800 21 $0
J9144 Injection, daratumumab, 10 mg and hyaluronidase-fihj 10,440 14 $47
J9267 Injection, paclitaxel, 1 mg 6,322 14 $0

In context: peer comparison

Among 7 peers in Sarasota Medical Oncology Physician, average services per provider: 4,149. This provider delivers 63× the peer median.

Open Payments

Industry payments received

CMS Open Payments
All-time total
$4,288
Transactions
112
Manufacturers
15
Payer (manufacturer) Industry Txns Amount
Daiichi Sankyo INC. 6 $1,079.89
Celgene Corporation 13 $421.72
Pfizer INC. 15 $332.54
E.R. Squibb & Sons, L.L.C. 12 $232.16
Novartis Pharmaceuticals Corporation 11 $212.91
Janssen Biotech, INC. 11 $169.44
Merck Sharp & Dohme LLC 6 $154.44
Array Biopharma INC 6 $149.02
AstraZeneca Pharmaceuticals Lp 7 $144.29
Abbvie INC. 6 $134.69
Rigel Pharmaceuticals, INC. 2 $132.77
BeiGene USA, INC. 5 $120.80
Incyte Corporation 5 $114.57
Takeda Pharmaceuticals U.S.A., INC. 4 $105.22
Eisai INC. 3 $77.93

By nature of payment

Food and Beverage
$3,348
Consulting Fee
$940

Medicare Part D · 2023

Top prescriptions

CMS Part D Prescriber
Total claims
1,579
Patients
526
Total drug cost
$2,093,340
Drug Type Claims Patients Total cost
Anastrozole Generic 162 38 $4,312
Eliquis (Apixaban) Brand 120 27 $112,135
Xarelto (Rivaroxaban) Brand 119 27 $116,666
Prednisone Generic 118 57 $705
Dexamethasone Generic 116 50 $2,064
Levothyroxine Sodium Generic 113 26 $1,330
Hydrocodone-Acetaminophen (Hydrocodone/Acetaminophen) Brand 111 46 $2,020
Pantoprazole Sodium Generic 109 41 $1,208
Gabapentin Generic 104 33 $1,477
Revlimid (Lenalidomide) Brand 99 16 $1,842,841

Hospital affiliations

CMS Hospital Compare

Frequently asked questions

Auto-generated from federal data
What is Dr. Fadi Kayali's medical specialty?
Dr. Fadi Kayali practices Medical Oncology Physician in Sarasota, FL.
Where does Dr. Fadi Kayali practice?
Dr. Fadi Kayali practices at 600 N Cattlemen RD, Sarasota, FL 342326422. Office phone: 9413779993.
What is Dr. Fadi Kayali's NPI?
Dr. Fadi Kayali's National Provider Identifier (NPI) is 1003031212, issued by NPPES.
Does Dr. Fadi Kayali accept Medicare assignment?
Yes. Dr. Fadi Kayali accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Fadi Kayali commonly perform?
Top Medicare-reported procedures in 2023: Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) (HCPCS Q0138); Injection, nivolumab, 1 mg (HCPCS J9299); Injection, pembrolizumab, 1 mg (HCPCS J9271). Source: CMS Medicare Physician & Other Practitioners file.